FDA Names Top HHS Lawyer as Chief Counsel
FDA Names Top HHS Lawyer as Chief Counsel
http://www.fda.gov/news-events/press-announcements/fda-names-top-hhs-lawyer-chief-counsel
FDA Names Top HHS Lawyer as Chief Counsel
http://www.fda.gov/news-events/press-announcements/fda-names-top-hhs-lawyer-chief-counsel
FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
http://www.fda.gov/news-events/press-announcements/fda-requires-major-changes-opioid-pain-medication-labeling-emphasize-risks
Cristina Mitchell
30 Jul 2025
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
http://www.fda.gov/news-events/press-announcements/fda-takes-steps-restrict-7-oh-opioid-products-threatening-american-consumers
Cristina Mitchell
29 Jul 2025
Cristina Mitchell
29 Jul 2025
Cristina Mitchell
28 Jul 2025
FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients
http://www.fda.gov/news-events/press-announcements/fda-recommends-removal-voluntary-hold-elevidys-ambulatory-patients
Cristina Mitchell
28 Jul 2025